Analyst Ratings for Maravai LifeScience Holdings Inc. (MRVI)
MRVI Rating Summary
MRVI Price Target Summary
- Highest: $21.00 (Jefferies)
- Lowest: $6.00 (UBS)
- Average: $11.44
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$11.44 (+124.4%)
* Over Last 12-Mos
Rating Score: 5.5 / 10
Percentile Rank: 58%

Rating Score: 5.5 / 10

Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
8/8/2023 | KeyBanc | Paul Knight | Downgrade | Sector Weight (Overweight) |
N/A (N/A) |
11.50 (5.10) |
-55.65% | Details |
5/23/2023 | Credit Suisse » Updated 8/8/2023 |
Dan Leonard | Downgrade | Neutral (Outperform) |
11.00 (14.00) |
13.38 (5.10) |
-61.88% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |